Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 162

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Liquid Chromatography−Mass Spectrometry-Based Parallel Metabolic Profiling of Human and Mouse Model Serum Reveals Putative Biomarkers Associated with the Progression of Nonalcoholic Fatty Liver Disease

Open access
Barr, Jonathan, Vázquez-Chantada, Mercedes, Alonso, Cristina, Pérez-Cormenzana, Miriam, Mayo, Rebeca, Galán, Asier, Caballería, Juan, Martín-Duce, Antonio, Tran, Albert, Wagner, Conrad, Luka, Zigmund, Lu, Shelly C., Castro, Azucena, Le Marchand-Brustel, Yannick, Martínez-Chantar, M. Luz, Veyrie, Nicolas, Clément, Karine, Tordjman, Joan, Gual, Philippe, Mato, José M. · 2010 · Journal of Proteome Research

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease in most western countries. Current NAFLD diagnosis methods (e.g., liver biopsy analysis or imaging techniques) are poorly suited as tests for such a prevalent condition, from both a clinical and financial point of view. The present work aims to demonstrate the potential utility of serum metabolic profiling in defining phenotypic biomarkers that could be useful in NAFLD management. A parallel animal model/human NAFLD exploratory metabolomics approach was employed, using ultra performance liquid chromatography-mass spectrometry (UPLC-MS) to analyze 42 serum samples collected from nondiabetic, morbidly obese, biopsy-proven NAFLD patients, and 17 animals belonging to the glycine N-methyltransferase knockout (GNMT-KO) NAFLD mouse model. Multivariate statistical analysis of the data revealed a series of common biomarkers that were significantly altered in the NAFLD (GNMT-KO) subjects in comparison to their normal liver counterparts (WT). Many of the compounds observed could be associated with biochemical perturbations associated with liver dysfunction (e.g., reduced Creatine) and inflammation (e.g., eicosanoid signaling). This differential metabolic phenotyping approach may have a future role as a supplement for clinical decision making in NAFLD and in the adaption to more individualized treatment protocols.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/pr1002593

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 88

  1. Reid A. E., 2001, Gastroenterology, 121, 710, 10.1053/gast.2001.27126 · DOI · Paper page
  2. Clark J. M., 2003, Gastroenterology, 124, 248, 10.1053/gast.2003.50032 · DOI · Paper page
  3. Marchesini G., 2003, Hepatology, 37, 917, 10.1053/jhep.2003.50161 · DOI · Paper page
  4. Adams L. A., 2007, Ann. Epidemiol., 17, 863, 10.1016/j.annepidem.2007.05.013 · DOI · Paper page
  5. Angulo P., 2007, Nutr. Rev., 65, S57, 10.1301/nr.2007.jun.S57-S63 · DOI · Paper page
  6. Parekh S., 2007, Gastroenterology, 132, 2191, 10.1053/j.gastro.2007.03.055 · DOI · Paper page
  7. Caldwell S. H., 2004, Gastroenterology, 127, S97, 10.1053/j.gastro.2004.09.021 · DOI · Paper page
  8. El-Serag H. B., 2004, Gastroenterology, 127, S27, 10.1053/j.gastro.2004.09.013 · DOI · Paper page
  9. Malhi H., 2008, Semin. Liver Dis., 28, 360, 10.1055/s-0028-1091980 · DOI · Paper page
  10. Mato J. M., 2007, Hepatology, 45, 1306, 10.1002/hep.21650 · DOI · Paper page
  11. Mato J. M., 2008, Annu. Rev. Nutr., 28, 273, 10.1146/annurev.nutr.28.061807.155438 · DOI · Paper page
  12. Tordjman J., 2009, J. Hepatol., 51, 354, 10.1016/j.jhep.2009.02.031 · DOI
  13. Farrell G. C., 2006, Hepatology, 43, S99, 10.1002/hep.20973 · DOI · Paper page
  14. Klein S., 2006, Gastroenterology, 130, 1564, 10.1053/j.gastro.2006.01.042 · DOI · Paper page
  15. Wanless I. R., 1990, Hepatology, 12, 1106, 10.1002/hep.1840120505 · DOI · Paper page
  16. Marchesini G., 1999, Am. J. Med., 107, 450, 10.1016/S0002-9343(99)00271-5 · DOI · Paper page
  17. Marra F., 2008, Trends Mol. Med., 14, 72, 10.1016/j.molmed.2007.12.003 · DOI · Paper page
  18. Oh M. K., 2008, Aliment Pharmacol. Ther., 28, 503, 10.1111/j.1365-2036.2008.03752.x · DOI
  19. Ratziu V., 2005, Gastroenterology, 128, 1898, 10.1053/j.gastro.2005.03.084 · DOI · Paper page
  20. Castera L., 2006, Hepatology, 43, 373, 10.1002/hep.21019 · doi:10.1002/hep.21019
  21. Kotronen A., 2009, Gastroenterology, 137, 865, 10.1053/j.gastro.2009.06.005 · DOI · Paper page
  22. Poynard T, I.-B. F., 2004, Comp. Hepatol., 4, 10, 10.1186/1476-5926-4-10 · DOI · Paper page
  23. Imbert-Bismut F., 2004, Clin. Chem. Lab. Med., 42, 323, 10.1515/CCLM.2004.058 · DOI
  24. Poynard T., 2005, Comp. Hepatol., 4, 10, 10.1186/1476-5926-4-10 · DOI · Paper page
  25. Poynard T., 2006, BMC Gastroenterol., 6, 34, 10.1186/1471-230X-6-34 · DOI · Paper page
  26. Morra R., 2007, Expert Rev. Mol. Diagn., 7, 481, 10.1586/14737159.7.5.481 · doi:10.1586/14737159.7.5.481
  27. Guha I. N., 2008, Hepatology, 47, 455, 10.1002/hep.21984 · DOI · Paper page
  28. Guha I. N., 2008, Clin. Liver Dis., 12, 883, 10.1016/j.cld.2008.07.010 · DOI
  29. Nicholson J. K., 2002, Nat. Rev. Drug Discovery, 1, 153, 10.1038/nrd728 · DOI · Paper page
  30. Nicholson J. K., 1999, Xenobiotica, 29, 1181, 10.1080/004982599238047 · DOI · Paper page
  31. Gowda G. A., 2008, Expert Rev. Mol. Diagn., 8, 617, 10.1586/14737159.8.5.617 · DOI · Paper page
  32. Kaddurah-Daouk R., 2008, Annu. Rev. Pharmacol. Toxicol., 48, 653, 10.1146/annurev.pharmtox.48.113006.094715 · DOI · Paper page
  33. Heijne W. H., 2005, Expert Rev. Proteomics, 2, 767, 10.1586/14789450.2.5.767 · DOI · Paper page
  34. Varela-Rey M., 2009, Int. J. Biochem. Cell Biol., 41, 969, 10.1016/j.biocel.2008.10.027 · DOI
  35. Ariz, U.; Mato, J. M.; Lu, S. C.; Martinez Chantar, M. L.Nonalcoholic steatohepatitis, animal models, and biomarkers: what is new?Methods in Molecular Biology;Humana Press:Totowa, NJ, 2010; Vol.593, pp109−36. · DOI
  36. Martinez-Chantar M. L., 2008, Hepatology, 47, 1191, 10.1002/hep.22159 · DOI · Paper page
  37. Kotb M., 1997, Trends Genet, 13, 51, 10.1016/S0168-9525(97)01013-5 · DOI · Paper page
  38. Avila M. A., 2002, Alcohol, 27, 163, 10.1016/S0741-8329(02)00228-8 · DOI
  39. Corrales F. J., 2002, J. Nutr., 132, 2377S, 10.1093/jn/132.8.2377S · DOI
  40. Martinez-Chantar M. L., 2002, Am. J. Clin. Nutr., 76, 1177S, 10.1093/ajcn/76.5.1177S · DOI
  41. Finkelstein J. D., 2007, Clin. Chem. Lab. Med., 45, 1694, 10.1515/CCLM.2007.341 · DOI · Paper page
  42. Heady J. E., 1975, Cancer Res., 35, 640
  43. Chen S. Y., 2004, Cancer Res., 64, 3617, 10.1158/0008-5472.CAN-03-3726 · doi:10.1158/0008-5472.can-03-3726
  44. Luka Z., 2006, Transgenic Res., 15, 393, 10.1007/s11248-006-0008-1 · DOI
  45. Griffiths W. J., 2007, Eur. J. Mass Spectrom. (Chichester, England), 13, 45, 10.1255/ejms.850 · DOI
  46. Burton L., 2008, J. Chromatogr., B: Analyt. Technol. Biomed. Life Sci., 871, 227, 10.1016/j.jchromb.2008.04.044 · DOI
  47. Theodoridis G. G., 2008, Trends Anal. Chem., 27, 238, 10.1016/j.trac.2008.01.008 · DOI · Paper page
  48. Bedair M. S., 2008, Trends Anal. Chem., 27, 251, 10.1016/j.trac.2008.01.006 · DOI · Paper page
  49. Wold S, J. E., 1993, 3D-QSAR in drug design, theory, methods, and applications
  50. Jolliffe I. T., 2002, Principal component analysis
  51. Bylesö M., 2006, J. Chemometrics, 20, 341, 10.1002/cem.1006 · DOI · Paper page
  52. Wiklund S., 2008, Anal. Chem., 80, 115, 10.1021/ac0713510 · DOI · Paper page
  53. Brugger B., 1997, Proc. Natl. Acad. Sci. U.S.A., 94, 2339, 10.1073/pnas.94.6.2339 · DOI · Paper page
  54. Khaselev N., 2000, J. Am. Soc. Mass Spectrom., 11, 283, 10.1016/S1044-0305(99)00158-0 · DOI
  55. Han X. G. R. W., 1996, J. Am. Chem. Soc., 118, 451, 10.1021/ja952326r · doi:10.1021/ja952326r
  56. Houjou T., 2004, Rapid Commun. Mass Spectrom., 18, 3123, 10.1002/rcm.1737 · DOI
  57. Duce A. M., 1988, Hepatology, 8, 65, 10.1002/hep.1840080113 · DOI · Paper page
  58. Kharbanda K. K., 2007, J. Hepatol., 46, 314, 10.1016/j.jhep.2006.08.024 · DOI · Paper page
  59. Ikura Y., 2006, Hepatology, 43, 506, 10.1002/hep.21070 · DOI
  60. Li Z., 2006, Cell Metab., 3, 321, 10.1016/j.cmet.2006.03.007 · DOI · Paper page
  61. Nanji A. A., 1981, Clin. Chem., 27, 1954, 10.1093/clinchem/27.11.1954 · doi:10.1093/clinchem/27.11.1954
  62. Malnick S. D., 1994, Hepatology, 19, 261, 10.1002/hep.1840190142 · doi:10.1002/hep.1840190142
  63. Vaubourdolle M., 1993, Hepatology, 17, 423, 10.1002/hep.1840170312 · doi:10.1002/hep.1840170312
  64. Gentile C. L., 2008, J. Nutr. Biochem., 19, 567, 10.1016/j.jnutbio.2007.10.001 · DOI · Paper page
  65. Kotronen A., 2009, Diabetes, 58, 203, 10.2337/db08-1074 · DOI · Paper page
  66. Bass N. M., 2010, Hepatology, 51, 4, 10.1002/hep.23458 · DOI
  67. Kunos G., 2008, Am. J. Physiol. Gastrointest. Liver Physiol., 294, G1101, 10.1152/ajpgi.00057.2008 · DOI
  68. Six D. A., 2000, Biochim. Biophys. Acta, 1488, 1
  69. Kudo I., 2002, Prostaglandins Other Lipid Mediat., 68, 3, 10.1016/S0090-6980(02)00020-5 · DOI · Paper page
  70. Leslie C. C., 1988, Biochim. Biophys. Acta, 963, 476, 10.1016/0005-2760(88)90316-5 · DOI · Paper page
  71. Schievella A. R., 1995, J. Biol. Chem., 270, 30749, 10.1074/jbc.270.51.30749 · DOI · Paper page
  72. Pawliczak R., 2004, J. Biol. Chem., 279, 48550, 10.1074/jbc.M408926200 · DOI
  73. Leslie C. C., 2004, Prostaglandins Leukot. Essent. Fatty Acids, 70, 373, 10.1016/j.plefa.2003.12.012 · DOI
  74. Hirabayashi T., 2004, Biol. Pharm. Bull., 27, 1168, 10.1248/bpb.27.1168 · DOI · Paper page
  75. Goetzl E. J., 2001, Prostaglandins Other Lipid Mediat., 64, 11, 10.1016/S0090-6980(01)00104-6 · doi:10.1016/s0090-6980(01)00104-6
  76. Kita T. K., 1999, Diabetes Res. Clin. Pract., 45, 123, 10.1016/S0168-8227(99)00041-8 · DOI
  77. Yang L., 2008, Chem. Res. Toxicol., 21, 2280, 10.1021/tx800225q · DOI
  78. Monte M. J., 2009, World J. Gastroenterol., 15, 804, 10.3748/wjg.15.804 · DOI · Paper page
  79. Perez M. J., 2009, World J. Gastroenterol., 15, 1677, 10.3748/wjg.15.1677 · DOI · Paper page
  80. Gilat T., 2003, Hepatology, 38, 436, 10.1053/jhep.2003.50348 · DOI
  81. Kobayashi N., 2002, Steroids, 67, 827, 10.1016/S0039-128X(02)00036-3 · doi:10.1016/s0039-128x(02)00036-3
  82. Mari M., 2004, J. Clin. Invest., 113, 895, 10.1172/JCI200419852 · doi:10.1172/jci200419852
  83. Mari M., 2007, Liver Int., 27, 440, 10.1111/j.1478-3231.2007.01475.x · doi:10.1111/j.1478-3231.2007.01475.x
  84. Morales A., 2007, Apoptosis, 12, 923, 10.1007/s10495-007-0721-0 · DOI · Paper page
  85. Engelmann B., 2004, Biochem. Soc. Trans., 32, 147, 10.1042/bst0320147 · DOI · Paper page
  86. Zoeller R. A., 1999, Biochem. J., 338, 769, 10.1042/bj3380769 · DOI · Paper page
  87. Tominaga T., 1993, Alcohol Alcohol Suppl., 1, 103, 10.1093/alcalc/28.Supplement_1A.103 · doi:10.1093/alcalc/28.supplement_1a.103
  88. Xie Z., 2010, Metabolism, 59, 554, 10.1016/j.metabol.2009.08.022 · DOI

Cited by

See all 162

Metadata

Authors
Barr, J., Vázquez-Chantada, M., Alonso, C., Pérez-Cormenzana, M., Mayo, R., Galán, A., Caballería, J., Martín-Duce, A., Tran, A., Wagner, C., Luka, Z., Lu, S. C., Castro, A., Le Marchand-Brustel, Y., Martínez-Chantar, M. L., Veyrie, N., Clément, K., Tordjman, J., Gual, P., & Mato, J. M.
Venue
Journal of Proteome Research
Published
2010-08-04
Volume
9
Issue
9
Pages
4501-4512
ISSN
  • 1535-3893 (ISSN-L)
  • 1535-3907
OpenAlex
W2087843153
Cited by
162
References
6
FWCI
5.32
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.